Skip to main content
Clinical Trials/NL-OMON31988
NL-OMON31988
Not yet recruiting
Not Applicable

Sex chromosome abnormality as co-finding when performing routine prenatal diagnostic procedures: diagnostic gain or damage? Study on the views of parents and professionals. - Routine fetal gender determination in prenatal testing: gain or damage?

niversitair Medisch Centrum Sint Radboud0 sites30 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
foetale geslachtsbepaling
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
30
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • Parents that have undergone an invasive prenatal diagnostic test in the last 15 years in the Nijmegen region because of maternal age or to exclude other serious chromosomal anomalies, who were faced with a fetal sex chromosomal abnormality as a co\-finding in the karyotyping procedure.

Exclusion Criteria

  • . Patients with a clear risk at a sex chromosomal abnormality, because of an earlier child with this same problem.
  • . Patients with insufficient fluency in Dutch.

Outcomes

Primary Outcomes

Not specified

Similar Trials